—
Hypoparathyroidism - Pipeline Review, H1 2017 market research report adds on ReportsnReports.com store. The Hypoparathyroidism pipeline guide evaluates Hypoparathyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.Browse Hypoparathyroidism Pipeline report has 7 Company Profiles, 14 Tables and 10 Figures, Spread across 43 Pages Report Available at http://www.reportsnreports.com/reports/1010771-hypoparathyroidism-pipeline-review-h1-2017.html .
Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping and twitching of muscles (involuntary muscle contraction), and several other symptoms. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The treatment includes artificial form of the hormone that can be administered as replacement, calcium replacement or vitamin.
Main key players of Ulcerative Colitis are Ascendis Pharma A/S, Chugai Pharmaceutical Co Ltd, Eli Lilly and Company, Entera Bio Ltd, Pharis Biotec GmbH, Shire Plc
Discount Available at http://www.reportsnreports.com/contacts/discount.aspx?name=1010771 (This report is available at upto 25% Discount till June 02nd 2017.)
Hypoparathyroidism - Drug Profiles are hPTH-137, parathyroid hormone, PCO-371, PTH-RM, teriparatide.
Hypoparathyroidism - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hypoparathyroidism (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Hypoparathyroidism (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Order a copy of this research report at http://www.reportsnreports.com/purchase.aspx?name=1010771
Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Hypoparathyroidism (Hormonal Disorders). The pipeline guide reviews pipeline therapeutics for Hypoparathyroidism (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide reviews key companies involved in Hypoparathyroidism (Hormonal Disorders) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Hypoparathyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Hypoparathyroidism (Hormonal Disorders).
Table of Contents
Hypoparathyroidism - Overview
Hypoparathyroidism - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Hypoparathyroidism - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hypoparathyroidism - Companies Involved in Therapeutics Development
Related Report
Hypothyroidism - Pipeline Review, H1 2017 : The pipeline guide reviews key companies involved in Hypothyroidism (Hormonal Disorders) therapeutics and enlists all their major and minor projects. Companies Involved in Therapeutics Development: Genexine Inc, Synthonics Inc, Titan Pharmaceuticals Inc.
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports.com
Website: http://www.reportsnreports.com/reports/1010771-hypoparathyroidism-pipeline-review-h1-2017.html
Release ID: 203007
Google
RSS